Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Report: Health System Not Ready for Alzheimer’s Therapies

A new study finds the U.S. health care system does not have the capacity for large-scale screening and treatment of people with early indicators of Alzheimer’s disease. . . . → Read More: Report: Health System Not Ready for Alzheimer’s Therapies

Trial Underway Testing Personal RNA Cancer Drug

A clinical trial is underway testing a treatment for solid tumor cancers derived from messenger RNA, genetic material with protein coding instructions for cells. . . . → Read More: Trial Underway Testing Personal RNA Cancer Drug

Two Opioid Addiction Treatments Found Safe, Effective

A clinical trial testing two leading therapies for opioid abuse found the treatments both safe and effective, even though they work in different ways. . . . → Read More: Two Opioid Addiction Treatments Found Safe, Effective

Alliance Exploring Microbiome on Cancer Immunotherapy

A biotechnology company and two research institutes are collaborating on a study of a proposed cancer treatment that targets the microbiome, communities of bacteria in the human body. . . . → Read More: Alliance Exploring Microbiome on Cancer Immunotherapy

Sanofi Acquires Multiple Sclerosis Drug in $800M Deal

Drug maker Sanofi is licensing a drug candidate from Principia Biopharma Inc. designed to treat multiple sclerosis, an autoimmune condition affecting the brain and nervous system. . . . → Read More: Sanofi Acquires Multiple Sclerosis Drug in $800M Deal

Virtual Reality Shown to Reduce Blood Draw Pain in Kids

Findings from a clinical trial show the use of virtual reality can prevent much of the pain and anxiety in children when drawing blood for tests. . . . → Read More: Virtual Reality Shown to Reduce Blood Draw Pain in Kids

Plasma Infusions to Treat Alzheimer’s Shown Safe

Results from a small-scale clinical trial indicate treatments with plasma infusions from young donors are safe for patients and may improve functional abilities. . . . → Read More: Plasma Infusions to Treat Alzheimer’s Shown Safe

Report – 126 Alzheimer’s Drugs in Clinical Trials

A foundation supporting research on new drugs to treat Alzheimer’s disease says clinical trials now underway are testing 126 potential therapies for the disorder. . . . → Read More: Report – 126 Alzheimer’s Drugs in Clinical Trials

Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Drug maker Novartis is purchasing a company that develops therapies and diagnostics using radio isotopes for neuroendocrine and other cancers. . . . → Read More: Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Here’s What a Real Opioid Emergency Looks Like

Let’s be clear — the limited steps ordered by the president to reduce the numbers of people addicted to opioids don’t look anything like a response to an emergency. . . . → Read More: Here’s What a Real Opioid Emergency Looks Like